Theriva Biologics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Theriva Biologics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
  • Theriva Biologics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.13M shares, a 66.4% increase year-over-year.
  • Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 16.1M shares, a 5.09% increase from 2022.
  • Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.3M shares, a 25.8% increase from 2021.
  • Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 12.2M shares, a 35.9% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.13M +453K +66.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 19.4M +4.23M +27.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 17.1M +2.02M +13.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 16.1M +780K +5.09% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 682K -15.2M -95.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 15.2M -678K -4.28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 15.1M +1.3M +9.44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 15.3M +3.14M +25.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 15.8M +2.64M +20% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 15.8M +2.64M +20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 13.8M -77M -84.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 12.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 13.2M -6.19M -31.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 13.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 90.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 19.4M +2.59M +15.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q3 2019 16.8M +12.8M +317% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-04
Q2 2019 16.5M +12.8M +347% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 15.7M +12M +326% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 13.4M +9.77M +266% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-27
Q3 2018 4.03M +363K +9.91% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 3.68M +169K +4.81% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 3.67M +318K +9.47% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 3.67M -100M -96.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 3.67M -87.8M -96% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 3.51M -90.4M -96.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 3.36M -87.5M -96.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 104M +13M +14.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 91.4M +3.86M +4.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-22
Q2 2016 93.9M +21.2M +29.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-22
Q1 2016 90.8M +18.2M +25% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-22
Q4 2015 90.8M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 87.6M +29.1M +49.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 72.7M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 72.7M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q3 2014 58.5M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2011 27.9M +6M +27.4% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-15
Q2 2010 21.9M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.